Facial Lines: IPN10200 Treatment Study

We are studying a new treatment for adults with moderate to severe upper facial lines to see if it improves their appearance compared to a placebo. The trial will assess both safety and effectiveness of the treatment.

6-12 months 6-10 visits Safety phase (I)Efficacy phase (II)Post-Trial Drug Access Investigational Medicines InjectionDermatology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Botox

Botox is a medicine used to relax muscles to reduce facial wrinkles and treat certain muscle- and nerve-related conditions.

Dysport

Dysport is a medicine injected to temporarily relax muscles, often used to smooth facial wrinkles and treat certain muscle stiffness.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Botulinum Antitoxin Type A Ph. Eur.

Botulinum antitoxin type A is a substance that neutralizes botulinum toxin to treat and prevent worsening paralysis caused by botulism.

Botulinum Toxin Type A

Botulinum toxin type A is a substance that temporarily relaxes muscles to reduce wrinkles and treat muscle overactivity.

Botulinum Toxin Type A - Haemagglutinin Complex

Botulinum toxin type A with haemagglutinin complex temporarily relaxes muscles by blocking nerve signals to treat muscle spasms and reduce wrinkles.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Ipn10200

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Alluzience

Azzalure

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

Mediti S.A.S.

Antibes, France

Thinkin

Levallois-Perret, France

Aimed S.A.S.

Lyon, France

Sponsor: Ipsen Innovation

Last updated: Nov 27, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.